mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |